Pharmaceutical research, 2017-09, Vol.34 (9), p.1751-1753
2017
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- High-Tech Drugs in Creaky Formulations
- Ist Teil von
- Pharmaceutical research, 2017-09, Vol.34 (9), p.1751-1753
- Ort / Verlag
- New York: Springer US
- Erscheinungsjahr
- 2017
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- Recent literature reviews and registration documents covering novel Signal Transduction Inhibitors in the treatment of cancer paint a picture of inefficiency and variability, where formulation improvements could be valuable. In this article, we discuss apparent drug design flaws as we impose the current standard formulation practice.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0724-8741eISSN: 1573-904XDOI: 10.1007/s11095-017-2185-4Titel-ID: cdi_proquest_miscellaneous_1904206293
- Format
- –
- Schlagworte
- Antimitotic agents, Antineoplastic agents, Antineoplastic Agents - chemistry, Antineoplastic Agents - pharmacokinetics, Antineoplastic Agents - pharmacology, Biochemistry, Biomedical and Life Sciences, Biomedical Engineering and Bioengineering, Biomedicine, Biopharmaceutics - methods, Cancer, Cellular signal transduction, Chemotherapy, Design standards, Drug Compounding - methods, Drug Design, Drug development, Formulations, Humans, Literature reviews, Medical Law, Molecular Targeted Therapy, Neoplasms - drug therapy, Neoplasms - metabolism, Nilotinib, Perspective, Pharmacology/Toxicology, Pharmacy, Signal transduction, Signal Transduction - drug effects, Solubility